Visit and procedure schedule in a clinical trial – how to create it?
A well-designed schedule of visits and procedures is the foundation of a smoothly conducted study—often underestimated at the design stage, yet crucial for successful execution. It is this schedule that research teams rely on to organize their work and manage participant treatment and follow-up. The starting point is always the study protocol, but simply transferring protocol requirements into a visit table is not enough. What matters is understanding the logic of the study—what data are critical, when they need to be collected, and what dependencies exist between individual procedures. Only then can the visit structure be designed effectively.
The next step is to identify all procedures required in the study—both those related to efficacy assessment and those focused on safety. These procedures should be grouped strategically to maximize the value of each visit and reduce the total number of visits whenever possible. An overly complex schedule can increase the burden on both investigators and participants, which may raise the risk of dropout or protocol deviations.
Equally important is defining visit frequency and incorporating visit windows. These allow flexibility in executing the schedule without compromising data quality. This is especially relevant in practice, where patient availability, site workflows, or unforeseen circumstances may affect exact visit timing.
Operational realities also need to be considered. Even the most scientifically sound schedule can prove unworkable if it does not reflect site capabilities or the time required for procedures. That is why the feasibility stage is so important—it allows assumptions to be tested in practice and adjusted before the study begins.
Regulatory requirements and quality standards are another critical consideration. The schedule must support appropriate safety monitoring and reliable data reporting. Special attention should be given to visits related to adverse event assessments, sample collection, or administration of the investigational medicinal product.
The final output of this process is a clear Schedule of Assessments, usually presented in tabular form, which becomes one of the key working tools for all teams involved in the study. Its quality directly affects study efficiency, data consistency, and participant experience.
A well-planned schedule not only structures the conduct of the study but also minimizes the risk of errors and improves communication among all stakeholders. This is exactly where support from an experienced CRO partner can significantly reduce the risk of costly protocol amendments in later project stages.
Biostat experts support sponsors in defining the optimal endpoint structure, designing statistical analysis plans, and ensuring alignment with current regulatory guidance and Good Clinical Practice standards.
If you are planning a clinical or observational study and want to ensure its analytical potential is fully utilized, contact the Biostat team—we can help design a study that delivers not only the required results, but also real scientific and business value.
